Updated 19 March 2018

Blood clots common in COPD patients

One in four patients hospitalised with COPD will have a blood clot in their lungs. This is a potentially life-threatening problem.

A review of prior research suggests that up to one in four patients who are hospitalised for worsening chronic obstructive pulmonary disease (COPD) will have a blood clot in their lungs, a potentially life-threatening problem called pulmonary embolism.

COPD, a progressive disease that makes it hard to breathe, can cause coughing that produces large amounts of mucus, wheezing, shortness of breath, chest tightness, and other symptoms.

The causes of COPD
Cigarette smoking is the leading cause of COPD - most people who have COPD smoke or used to smoke, but it is also associated with long-term exposure to other lung irritants, such as air pollution and chemical fumes.

The two main components are emphysema and chronic obstructive bronchitis, which both damage the walls of the lung, making breathing difficult.

"A diagnosis of pulmonary embolism should be considered in patients with (COPD flare-ups) severe enough to warrant hospitalisation," Dr. Don D. Sin, from the University of British Columbia, Vancouver, and colleagues advise.

In roughly 30% of COPD flare-ups, the cause is unclear, according to the report in the journal Chest. Although COPD patients are known to be at risk for pulmonary embolism, the exact frequency of pulmonary embolism during flare-ups was not known.

The review
The current review featured five studies drawn from 2,407 published papers identified through a medical database search. All told, data from 550 patients were included in the analysis.

The findings suggest that one in five patients with a COPD flare-up had a pulmonary embolism. In COPD patients hospitalised for their flare-up, however, the rate of pulmonary embolism was even higher, about one in four.

No differences in the initial signs or symptoms were seen between patients who did and did not have a pulmonary embolism, the report shows.

The authors call for a large, multicentre study to examine this topic, noting that although reviews, such as the present one, "are useful tools to synthesise the existing body of evidence, they cannot substitute for the findings of large, well-conducted clinical trials."

(Reuters Health, March 2009)

(Source: Chest, March 2009)


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.